Citigroup’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-57,615
| Closed | -$959K | – | 7754 |
|
|
2017
Q3 | $959K | Buy |
57,615
+9,460
| +20% | +$154K | ﹤0.01% | 3423 |
|
|
2017
Q2 | $862K | Buy |
48,155
+35,245
| +273% | +$658K | ﹤0.01% | 3467 |
|
|
2017
Q1 | $258K | Sell |
12,910
-22,016
| -63% | -$513K | ﹤0.01% | 4455 |
|
|
2016
Q4 | $875K | Buy |
34,926
+27,719
| +385% | +$655K | ﹤0.01% | 3838 |
|
|
2016
Q3 | $168K | Buy |
7,207
+241
| +3% | +$5.66K | ﹤0.01% | 4801 |
|
|
2016
Q2 | $139K | Sell |
6,966
-44,327
| -86% | -$827K | ﹤0.01% | 4816 |
|
|
2016
Q1 | $869K | Buy |
51,293
+39,831
| +348% | +$816K | ﹤0.01% | 3501 |
|
|
2015
Q4 | $255K | Buy |
11,462
+6,979
| +156% | +$145K | ﹤0.01% | 4516 |
|
|
2015
Q3 | $76K | Buy |
4,483
+235
| +6% | +$3.66K | ﹤0.01% | 5160 |
|
|
2015
Q2 | $59K | Sell |
4,248
-3,756
| -47% | -$49.9K | ﹤0.01% | 5412 |
|
|
2015
Q1 | $110K | Sell |
8,004
-5,897
| -42% | -$68K | ﹤0.01% | 4963 |
|
|
2014
Q4 | $147K | Buy |
13,901
+8,883
| +177% | +$105K | ﹤0.01% | 4936 |
|
|
2014
Q3 | $62K | Buy |
5,018
+2,243
| +81% | +$31.3K | ﹤0.01% | 5149 |
|
|
2014
Q2 | $38K | Sell |
2,775
-8,350
| -75% | -$109K | ﹤0.01% | 5358 |
|
|
2014
Q1 | $134K | Buy |
11,125
+2,256
| +25% | +$25.8K | ﹤0.01% | 4720 |
|
|
2013
Q4 | $109K | Buy |
8,869
+4,163
| +88% | +$48.8K | ﹤0.01% | 5192 |
|
|
2013
Q3 | $48K | Sell |
4,706
-5,582
| -54% | -$52.2K | ﹤0.01% | 5318 |
|
|
2013
Q2 | $93K | Buy |
+10,288
| New | +$104K | ﹤0.01% | 4922 |
|
Citigroup's OME Position: Q4 2017 in Review
Citigroup sold out of Omega Protein (OME) in Q4 2017, closing a stake of 57,615 shares — an estimated $959K sold.
Citigroup first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $959K in Q3 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Citigroup reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Citigroup sold 57,615 Omega Protein shares in Q4 2017, an estimated $959K.
- Citigroup first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Citigroup's Omega Protein position peaked at $959K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.